{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:05:40Z","timestamp":1788455140623,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2022K7YKTY"],"award-info":[{"award-number":["PRIN 2022K7YKTY"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007353","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","award":["PNRR\\u2013 M4 C2 I1.1 -PRIN 2022CZTZ87- CUP F53D23006660006"],"award-info":[{"award-number":["PNRR\\u2013 M4 C2 I1.1 -PRIN 2022CZTZ87- CUP F53D23006660006"]}],"id":[{"id":"10.13039\/100007353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007353","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","award":["2209 - GRT-2023A"],"award-info":[{"award-number":["2209 - GRT-2023A"]}],"id":[{"id":"10.13039\/100007353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["1.5 -CUP F83B22000040006"],"award-info":[{"award-number":["1.5 -CUP F83B22000040006"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["M4-C2-Inv"],"award-info":[{"award-number":["M4-C2-Inv"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000073","name":"Autism Speaks","doi-asserted-by":"publisher","award":["11690"],"award-info":[{"award-number":["11690"]}],"id":[{"id":"10.13039\/100000073","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009880","name":"Regione Lazio","doi-asserted-by":"publisher","award":["A0375-2020-36550"],"award-info":[{"award-number":["A0375-2020-36550"]}],"id":[{"id":"10.13039\/501100009880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.phrs.2024.107176","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T22:58:13Z","timestamp":1712357893000},"page":"107176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors"],"prefix":"10.1016","volume":"203","author":[{"given":"Antonia","family":"Manduca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Buzzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Feo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Schiavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Peruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"D\u2019Oria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pezzullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pasquadibisceglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Polticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Micale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kuchar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Trezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.1016\/j.phrs.2024.107176_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0149-7634(03)00005-8","article-title":"Trajectories of brain development: point of vulnerability or window of opportunity?","volume":"27","author":"Andersen","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"18","key":"10.1016\/j.phrs.2024.107176_bib2","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1111\/bph.15181","article-title":"Interactions between cannabidiol and Delta(9) -tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome","volume":"177","author":"Anderson","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107176_bib3","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s10803-018-3808-2","article-title":"Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study","volume":"49","author":"Aran","year":"2019","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.phrs.2024.107176_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13229-019-0256-6","article-title":"Lower circulating endocannabinoid levels in children with autism spectrum disorder","volume":"10","author":"Aran","year":"2019","journal-title":"Mol. Autism"},{"issue":"1","key":"10.1016\/j.phrs.2024.107176_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13229-021-00420-2","article-title":"Cannabinoid treatment for autism: a proof-of-concept randomized trial","volume":"12","author":"Aran","year":"2021","journal-title":"Mol. Autism"},{"issue":"3","key":"10.1016\/j.phrs.2024.107176_bib6","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1152\/jn.00278.2019","article-title":"Object and place information processing by CA1 hippocampal neurons of C57BL\/6J mice","volume":"123","author":"Asgeirsdottir","year":"2020","journal-title":"J. Neurophysiol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107176_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s11689-022-09466-6","article-title":"A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)","volume":"14","author":"Berry-Kravis","year":"2022","journal-title":"J. Neurodev. Disord."},{"issue":"4","key":"10.1016\/j.phrs.2024.107176_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107176_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-022-06286-3","article-title":"Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome","volume":"240","author":"Buzzelli","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2024.107176_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neubiorev.2020.12.009","article-title":"Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story","volume":"121","author":"Carbone","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.phrs.2024.107176_bib11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107176_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.phrs.2024.107176_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"de Almeida","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"issue":"1","key":"10.1016\/j.phrs.2024.107176_bib14","doi-asserted-by":"crossref","first-page":"22535","DOI":"10.1038\/s41598-022-26986-2","article-title":"FMR1 deletion in rats induces hyperactivity with no changes in striatal dopamine transporter availability","volume":"12","author":"D'Elia","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107176_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fphar.2016.00370","article-title":"A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)","volume":"7","author":"Deutsch","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107176_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/epi.14628","article-title":"Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial","volume":"60","author":"Devinsky","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2024.107176_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105357","article-title":"Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Delta9-tetrahydrocannabinol-exposed rats","volume":"164","author":"Di Bartolomeo","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2024.107176_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbr.2014.05.046","article-title":"Behavioral analysis of male and female Fmr1 knockout mice on C57BL\/6 background","volume":"271","author":"Ding","year":"2014","journal-title":"Behav Brain Res"},{"issue":"14","key":"10.1016\/j.phrs.2024.107176_bib19","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1074\/jbc.M114.618447","article-title":"Fatty acid-binding proteins (FABPs) are intracellular carriers for Delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD)","volume":"290","author":"Elmes","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2024.107176_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/adar.2023.11163","article-title":"Acute cannabidiol treatment enhances social interaction in adult male mice","volume":"3","author":"Ferreira","year":"2023","journal-title":"Adv. Drug Alcohol Res."},{"issue":"1","key":"10.1016\/j.phrs.2024.107176_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/0192623315596858","article-title":"Recommended Methods for Brain Processing and Quantitative Analysis in Rodent Developmental Neurotoxicity Studies","volume":"44","author":"Garman","year":"2016","journal-title":"Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107176_bib22","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/cercor\/bhz029","article-title":"Deletion of the KH1 Domain of Fmr1 Leads to Transcriptional Alterations and Attentional Deficits in Rats","volume":"29","author":"Golden CEM","year":"2019","journal-title":"Cereb. Cortex"},{"issue":"4","key":"10.1016\/j.phrs.2024.107176_bib23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neuron.2012.09.036","article-title":"Hippocampal pyramidal neurons comprise two distinct cell types that are countermodulated by metabotropic receptors","volume":"76","author":"Graves","year":"2012","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.phrs.2024.107176_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41398-022-02104-8","article-title":"Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study","volume":"12","author":"Hacohen","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107176_bib25","doi-asserted-by":"crossref","first-page":"17065","DOI":"10.1038\/nrdp.2017.65","article-title":"Fragile X syndrome","volume":"3","author":"Hagerman","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.phrs.2024.107176_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1037\/a0035988","article-title":"Fmr1 and Nlgn3 knockout rats: novel tools for investigating autism spectrum disorders","volume":"128","author":"Hamilton","year":"2014","journal-title":"Behav. Neurosci."},{"issue":"12","key":"10.1016\/j.phrs.2024.107176_bib27","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.euroneuro.2017.10.037","article-title":"Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC","volume":"27","author":"Hlozek","year":"2017","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"issue":"17","key":"10.1016\/j.phrs.2024.107176_bib28","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1111\/bph.15469","article-title":"Mechanisms of endocannabinoid transport in the brain","volume":"179","author":"Kaczocha","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.phrs.2024.107176_bib29","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1073\/pnas.0901515106","article-title":"Identification of intracellular carriers for the endocannabinoid anandamide","volume":"106","author":"Kaczocha","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.phrs.2024.107176_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094200","article-title":"Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia","volume":"9","author":"Kaczocha","year":"2014","journal-title":"PloS One"},{"issue":"42","key":"10.1016\/j.phrs.2024.107176_bib31","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1073\/pnas.1711351114","article-title":"Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome","volume":"114","author":"Kaplan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107176_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13229-018-0203-y","article-title":"Plasma anandamide concentrations are lower in children with autism spectrum disorder","volume":"9","author":"Karhson","year":"2018","journal-title":"Mol. Autism"},{"issue":"3","key":"10.1016\/j.phrs.2024.107176_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2024.107176_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21307\/ane-2018-001","article-title":"Possible role of hippocampal GPR55 in spatial learning and memory in rats","volume":"78","author":"Marichal-Cancino","year":"2018","journal-title":"Acta Neurobiol. Exp."},{"issue":"Pt 2","key":"10.1016\/j.phrs.2024.107176_bib35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neubiorev.2014.01.006","article-title":"Fragile X Syndrome: from molecular pathology to therapy","volume":"46","author":"Maurin","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2024.107176_bib36","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1093\/nar\/gky267","article-title":"HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein","volume":"46","author":"Maurin","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"18","key":"10.1016\/j.phrs.2024.107176_bib37","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1073\/pnas.1016167108","article-title":"Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH)","volume":"108","author":"Min","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"20","key":"10.1016\/j.phrs.2024.107176_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201600189","article-title":"Tubulin or Not Tubulin: Heading Toward Total Protein Staining as Loading Control in Western Blots","volume":"17","author":"Moritz","year":"2017","journal-title":"Proteomics"},{"issue":"16","key":"10.1016\/j.phrs.2024.107176_bib39","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.phrs.2024.107176_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.889636","article-title":"Sex Differences in Autism Spectrum Disorder: Diagnostic, Neurobiological, and Behavioral Features","volume":"13","author":"Napolitano","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"10","key":"10.1016\/j.phrs.2024.107176_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.800","article-title":"Deletion of Fmr1 results in sex-specific changes in behavior","volume":"7","author":"Nolan","year":"2017","journal-title":"Brain Behav."},{"issue":"7","key":"10.1016\/j.phrs.2024.107176_bib42","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/npp.2017.40","article-title":"Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model","volume":"42","author":"Osborne","year":"2017","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107176_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11689-023-09475-z","article-title":"Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment","volume":"15","author":"Palumbo","year":"2023","journal-title":"J. Neurodev. Disord."},{"issue":"12","key":"10.1016\/j.phrs.2024.107176_bib44","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1111\/bph.15003","article-title":"Cannabidiol improves survival and behavioural co-morbidities of Dravet syndrome in mice","volume":"177","author":"Patra","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2024.107176_bib45","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s00213-022-06196-4","article-title":"Cannabidiol for the treatment of autism spectrum disorder: hope or hype?","volume":"239","author":"Pedrazzi","year":"2022","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.phrs.2024.107176_bib46","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"issue":"13","key":"10.1016\/j.phrs.2024.107176_bib47","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.phrs.2024.107176_bib48","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.neubiorev.2021.11.031","article-title":"The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models","volume":"132","author":"Pietropaolo","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2024.107176_bib49","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41398-021-01612-3","article-title":"Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder","volume":"11","author":"Poleg","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107176_bib50","article-title":"Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review","author":"Rice","year":"2023","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.phrs.2024.107176_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41583-021-00432-0","article-title":"The molecular biology of FMRP: new insights into fragile X syndrome","volume":"22","author":"Richter","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.phrs.2024.107176_bib52","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nrn4001","article-title":"Dysregulation and restoration of translational homeostasis in fragile X syndrome","volume":"16","author":"Richter","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2024.107176_bib53","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tips.2008.12.004","article-title":"The enigmatic pharmacology of GPR55","volume":"30","author":"Ross","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2024.107176_bib54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ab.2019.03.010","article-title":"Ponceau S waste: Ponceau S staining for total protein normalization","volume":"575","author":"Sander","year":"2019","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.phrs.2024.107176_bib55","first-page":"8","article-title":"FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory","author":"Sawicka","year":"2019","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.phrs.2024.107176_bib56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41398-022-01885-2","article-title":"Phosphodiesterase 2A inhibition corrects the aberrant behavioral traits observed in genetic and environmental preclinical models of Autism Spectrum Disorder","volume":"12","author":"Schiavi","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2024.107176_bib57","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1080\/1028415X.2020.1819107","article-title":"Perinatal supplementation with omega-3 fatty acids corrects the aberrant social and cognitive traits observed in a genetic model of autism based on FMR1 deletion in rats","volume":"25","author":"Schiavi","year":"2022","journal-title":"Nutr. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2024.107176_bib58","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41386-022-01454-7","article-title":"Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats","volume":"48","author":"Schiavi","year":"2023","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2024.107176_bib59","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.phrs.2024.107176_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.815950","article-title":"Cannabidiol Increases Seizure Resistance and Improves Behavior in an Scn8a Mouse Model","volume":"13","author":"Shapiro","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107176_bib61","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pharmthera.2010.02.004","article-title":"Pharmacological characterization of GPR55, a putative cannabinoid receptor","volume":"126","author":"Sharir","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2024.107176_bib62","article-title":"Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind and controlled placebo clinical trial","volume":"44","author":"Silva","year":"2022","journal-title":"Trends Psychiatry Psychother."},{"issue":"11","key":"10.1016\/j.phrs.2024.107176_bib63","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1007\/s10803-013-1824-9","article-title":"Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders","volume":"43","author":"Siniscalco","year":"2013","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.phrs.2024.107176_bib64","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/FBP.0000000000000152","article-title":"Hyperactivity and lack of social discrimination in the adolescent Fmr1 knockout mouse","volume":"26","author":"Sorensen","year":"2015","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.phrs.2024.107176_bib65","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuropharm.2018.11.035","article-title":"Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia","volume":"146","author":"Stark","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2024.107176_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114004","article-title":"Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment","volume":"177","author":"Stark","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107176_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2021.718619","article-title":"Hippocampal CA1 Neurons Represent Positive Feedback During the Learning Process of an Associative Memory Task","volume":"15","author":"Takamiya","year":"2021","journal-title":"Front. Syst. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107176_bib68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/can.2018.0053","article-title":"Treatment of Fragile X Syndrome with Cannabidiol: A Case Series Study and Brief Review of the Literature","volume":"4","author":"Tartaglia","year":"2019","journal-title":"Cannabis cannabinoid Res."},{"issue":"3","key":"10.1016\/j.phrs.2024.107176_bib69","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaneurol.2020.4607","article-title":"Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial","volume":"78","author":"Thiele","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.phrs.2024.107176_bib70","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fnmol.2017.00269","article-title":"Loss of FMRP Impaired Hippocampal Long-Term Plasticity and Spatial Learning in Rats","volume":"10","author":"Tian","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107176_bib71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41593-018-0287-x","article-title":"Widespread RNA editing dysregulation in brains from autistic individuals","volume":"22","author":"Tran","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2024.107176_bib72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.phrs.2024.107176_bib73","first-page":"61","article-title":"Molecular Pharmacology of Phytocannabinoids","volume":"103","author":"Turner","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"key":"10.1016\/j.phrs.2024.107176_bib74","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fncel.2014.00150","article-title":"Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome","volume":"8","author":"Uutela","year":"2014","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"10.1016\/j.phrs.2024.107176_bib75","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ajhg.2018.10.009","article-title":"Human models are needed for studying human neurodevelopmental disorders","volume":"103","author":"Zhao","year":"2018","journal-title":"Am. J. Hum. Genet."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824001208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824001208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T03:37:15Z","timestamp":1714275435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824001208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":75,"alternative-id":["S1043661824001208"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107176","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107176"}}